Yearly Archives: 2025

Just over 42% of community pharmacy owners have completed the 2025/26 Community Pharmacy Assurance Framework (CPAF) screening questionnaire, with just under two weeks left to complete.   We encourage pharmacy owners who have not yet responded to the questionnaire to ensure they do so by Thursday, 31st July 2025. Completing the screening questionnaire is a [...]

The post CPAF Screening Questionnaire 2025/26 – less than two weeks left to complete appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (18/07/2025) confirmed the following initial list of price concessions for July 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.55 Amiloride 5mg tablets 28 £15.61 Betamethasone 500microgram soluble tablets sugar free 100 £33.00 Clarithromycin 125mg/5ml oral suspension 70 £5.88 Cyclizine 50mg/1ml solution for injection [...]

The post July 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

From 1 July 2025, the pack sizes of Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension have changed to reflect the final reconstituted volumes of the suspension after reconstitution. The pack size licensed for children weighing 4 kg and more is now expressed as a quantity of 103.4ml (previously 100ml bottle size). The pack size licensed [...]

The post Pack size changes – Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension appeared first on Community Pharmacy England.

Trade Press The Department of Health and Social Care (DHSC) has released new proposals today aimed at improving access to pharmacy services as part of its 10-Year Health Plan. These changes mean pharmacists will have more time to care for patients. Gordon Hockey, Director, Legal at Community Pharmacy England, said: “We welcome today’s proposals from the [...]

The post Our response to DHSC’s proposals: Freeing up pharmacists’ time to treat patients appeared first on Community Pharmacy England.

Community Pharmacy England earlier this week hosted a high-level policy discussion in Westminster on the value and potential of investing in community pharmacy, following publication of the 10-Year Health Plan. Healthwatch England, the national patient representative body, presented their latest report on public perceptions of community pharmacy, including high public satisfaction with Pharmacy First. And [...]

The post Policy groups discuss value of investing in pharmacy, following 10-Year Health Plan appeared first on Community Pharmacy England.